101 related articles for article (PubMed ID: 21707612)
21. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
[TBL] [Abstract][Full Text] [Related]
22. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro.
Zhu L; Shan LJ; Liu YJ; Chen D; Xiao XG; Li Y
J Dig Dis; 2014 Dec; 15(12):684-93. PubMed ID: 25214410
[TBL] [Abstract][Full Text] [Related]
23. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
[TBL] [Abstract][Full Text] [Related]
24. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
[TBL] [Abstract][Full Text] [Related]
26. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis.
Lukivskaya O; Zavodnik L; Knas M; Buko V
Adv Med Sci; 2006; 51():54-9. PubMed ID: 17357278
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
[TBL] [Abstract][Full Text] [Related]
28. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
[TBL] [Abstract][Full Text] [Related]
29. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients.
Carotti S; Guarino MP; Cicala M; Perrone G; Alloni R; Segreto F; Rabitti C; Morini S
Neurogastroenterol Motil; 2010 Aug; 22(8):866-73, e232. PubMed ID: 20426797
[TBL] [Abstract][Full Text] [Related]
30. A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid.
Castro RE; Solá S; Ma X; Ramalho RM; Kren BT; Steer CJ; Rodrigues CM
J Hepatol; 2005 Jun; 42(6):897-906. PubMed ID: 15885361
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
[TBL] [Abstract][Full Text] [Related]
32. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion.
Fiorotto R; Spirlì C; Fabris L; Cadamuro M; Okolicsanyi L; Strazzabosco M
Gastroenterology; 2007 Nov; 133(5):1603-13. PubMed ID: 17983806
[TBL] [Abstract][Full Text] [Related]
33. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
Miettinen TE; Tarpila S; Gylling H
Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
35. micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.
Chakass D; Philippe D; Erdual E; Dharancy S; Malapel M; Dubuquoy C; Thuru X; Gay J; Gaveriaux-Ruff C; Dubus P; Mathurin P; Kieffer BL; Desreumaux P; Chamaillard M
Gut; 2007 Jul; 56(7):974-81. PubMed ID: 17299060
[TBL] [Abstract][Full Text] [Related]
36. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
[TBL] [Abstract][Full Text] [Related]
38. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
39. The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis.
Lajczak-McGinley NK; Porru E; Fallon CM; Smyth J; Curley C; McCarron PA; Tambuwala MM; Roda A; Keely SJ
Physiol Rep; 2020 Jun; 8(12):e14456. PubMed ID: 32562381
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]